[HTML][HTML] An analysis of the sensitivity of proteogenomic mapping of somatic mutations and novel splicing events in cancer

KV Ruggles, Z Tang, X Wang, H Grover… - Molecular & Cellular …, 2016 - ASBMB
Improvements in mass spectrometry (MS)-based peptide sequencing provide a new
opportunity to determine whether polymorphisms, mutations, and splice variants identified in …

An analysis of the sensitivity of proteogenomic mapping of somatic mutations and novel splicing events in cancer

KV Ruggles, Z Tang, X Wang… - Molecular and …, 2016 - pure.johnshopkins.edu
Improvements in mass spectrometry (MS)-based peptide sequencing provide a new
opportunity to determine whether polymorphisms, mutations, and splice variants identified in …

An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer.

KV Ruggles, Z Tang, X Wang, H Grover… - Molecular & Cellular …, 2015 - europepmc.org
Improvements in mass spectrometry (MS)-based peptide sequencing provide a new
opportunity to determine whether polymorphisms, mutations, and splice variants identified in …

[HTML][HTML] An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer

KV Ruggles, Z Tang, X Wang, H Grover… - Molecular & Cellular …, 2016 - Elsevier
Improvements in mass spectrometry (MS)-based peptide sequencing provide a new
opportunity to determine whether polymorphisms, mutations, and splice variants identified in …

An analysis of the sensitivity of proteogenomic mapping of somatic mutations and novel splicing events in cancer

KV Ruggles, Z Tang, X Wang, H Grover… - Molecular & Cellular …, 2016 - edoc.mdc-berlin.de
Improvements in mass spectrometry (MS)-based peptide sequencing provide a new
opportunity to determine whether polymorphisms, mutations, and splice variants identified in …

[HTML][HTML] An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer

KV Ruggles, Z Tang, X Wang, H Grover… - Molecular & Cellular …, 2016 - ncbi.nlm.nih.gov
Improvements in mass spectrometry (MS)-based peptide sequencing provide a new
opportunity to determine whether polymorphisms, mutations, and splice variants identified in …

[引用][C] An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer

KV Ruggles, Z Tang, X Wang, H Grover… - Molecular & Cellular …, 2016 - cir.nii.ac.jp
An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel
Splicing Events in Cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer

KV Ruggles, Z Tang, X Wang, H Grover… - Molecular & Cellular …, 2016 - cdr.lib.unc.edu
Improvements in mass spectrometry (MS)-based peptide sequencing provide a new
opportunity to determine whether polymorphisms, mutations, and splice variants identified in …

[PDF][PDF] An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer

KV Ruggles, Z Tang, X Wang, H Grover, M Askenazi… - 2015 - academia.edu
Improvements in mass spectrometry (MS)-based peptide sequencing provide a new
opportunity to determine whether polymorphisms, mutations and splice variants identified in …

[PDF][PDF] An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer

KV Ruggles, Z Tang, X Wang, H Grover, M Askenazi… - 2015 - researchgate.net
Improvements in mass spectrometry (MS)-based peptide sequencing provide a new
opportunity to determine whether polymorphisms, mutations and splice variants identified in …